Circular RNAs are a large class of animal RNAs with regulatory potency
By Sebastian Memczak, Marvin Jens, Antigoni L Elefsinioti, F. Torti, Janna Krueger, Agnieszka Rybak, L. Maier, Sebastian D. Mackowiak, L. Gregersen, Mathias Munschauer and 6 more. Nature, 2013
7,259 citations recorded by the source corpus.
Subfields: Cancer Research, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/036377e98783b4fdf7c97e4f93511b00434bc29d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- Julia Salzman
- Ling-Ling Chen
- David P. Bartel
- Carlo Maria Croce
- George A. Calin
- Linda Szabo
- Li Yang
- Nikolaus Rajewsky
In Molecular Biology
- Julia Salzman
- Ling-Ling Chen
- David P. Bartel
- Li Yang
- Linda Szabo
- George A. Calin
- Carlo Maria Croce
- Nikolaus Rajewsky
Citations in the corpus
- Exosome Theranostics: Biology and Translational Medicine (2018, background): “Moreover, circRNAs can serve as sponges for microRNAs and proteins with stable, conservative, and tissue/developmental-stage-specific expression patterns [156].”
- CircInteractome: A web tool for exploring circular RNAs and their interacting proteins and microRNAs (2016, background): “In eukaryotes, circRNAs arise most often through backsplicing, a process in which the 5' and 3' ends of a spliced RNA are covalently linked to form a closed RNA molecule that contains exon and/or intron sequences.(1-3) Although a few examples of circRNAs have been known for several decades, only wit”
- circRNA biogenesis competes with pre-mRNA splicing. (2014, methodology): “Cotranscriptional Production of circRNAs Inspecting our own data (Memczak et al., 2013), we noticed that many circRNAs are generated from transcripts expressed in”
- Advances and Trends in Omics Technology Development (2022, background): “…been successfully applied to decode miRNA-target interactions (186), identify RNA binding sites of splicing factors (187, 188), investigate epigenetic modification-associated RNAs (189), and explore functions of ceRNAs (190), they suffer from several limitations that await additional improvements.”
- Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches. (2016, background): “In vivo studies revealed that a CiRS-7/CDR1as overexpression leads to a similar phenotype of impaired midbrain development than that of a miR-7 knockout mouse (186).”
- Circular RNA identification based on multiple seed matching (2018, methodology): “in cytoplasm [7, 8], nucleus-localized EIciRNAs were found to function as parental gene transcription activators [9].”
- Circular RNA (circRNA) in Alzheimer's disease (AD) (2013, background): “Intrinsically resistant to exonucleolytic RNA decay, circRNAs appear to be enriched in mammalian brain tissues (Hansen et al., 2013; Memczak et al., 2013).”
- CIRI: an efficient and unbiased algorithm for de novo circular RNA identification (2015, methodology): “Analyzing circRNAs identified from enormous RNA-seq data combined with sequencing data generated from additional samples has been adopted in several studies [11,13] and will probably continue to be a commonly used approach in further studies on circRNAs.”
- Circular RNAs: analysis, expression and potential functions (2016, background): “Another circRNA named ciRS-7, or sometimes simply CDR1as, which is derived from the Cdr1 antisense locus, also probably functions as a miRNA sponge (Hansen et al., 2013; Memczak et al., 2013).”
- Single-cell transcriptome sequencing: recent advances and remaining challenges (2016, methodology): “Finally, the bulk of scRNA-seq literature has focused solely on polya-denylated mRNAs; almost all published scRNA-seq protocols isolate cellular RNA by using poly-T priming, which captures only polya-denylated transcripts.”
- Metazoan MicroRNAs (2018, background): “in human and mouse Cdr1as, respectively) (Hansen et al., 2013; Memczak et al., 2013; Piwecka et al., 2017).”